 JUPITER, Fla., June 02, 2022 GLOBE NEWSWIRE -- Dyadic International, Inc. Dyadic, or the Company NASDAQ: DYAI, a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that its Chief Executive Officer, Mark Emalfarb will present at the 2022 Jefferies Healthcare Conference on Thursday, June 9, 2022, at 3:00 PM ET. 